FDA-Approved · Nasal Spray · In-Office Monitored Sessions · Serving Southfield & Berkshire County, MA
If you are in Southfield and exploring Spravato Southfield, MI, as a next step for depression that has not responded to standard medications, there is an FDA-approved option worth understanding. Southfield is a small town in Berkshire County, near the Connecticut border, and Modern Mind Clinic serves this community with Spravato treatment. Spravato (esketamine) nasal spray is FDA-approved for treatment-resistant depression (TRD) in adults and major depressive disorder (MDD) with acute suicidal ideation, used alongside an oral antidepressant. Sessions take place in a certified treatment center, involve no anesthesia, and include a two-hour monitoring period before you can safely head home.
Most patients get a decision within 24 hours. We handle insurance verification for you.
🔒No obligation. Your information is 100% confidential.
Accepted: Medicare · Medicaid · Tricare · Most Major Insurance Plans
Read how individuals from Southfield and neighboring Berkshire County communities found meaningful relief after traditional prescription medications failed to bring relief.
Spravato is an FDA-approved nasal spray medication derived from esketamine. It targets glutamate transmission in the brain, a different pathway than traditional antidepressants. For those seeking Spravato treatment near Southfield, our clinical practice delivers attentive, structured care in a certified office setting.
Your initial visit allows our clinical team to assess your symptoms, evaluate your medical background, and verify insurance benefits. Most patients receive coverage updates within 24 hours. The intake includes a thorough psychiatric assessment to determine if Spravato aligns with your treatment goals.
Spravato is administered under the direct supervision of a healthcare provider in our certified Spravato treatment center. Because of the risk of sedation, dissociation, and respiratory depression, you must be monitored for at least two hours after each dose. You cannot drive yourself home after treatment, so arrange transportation in advance. The SPRAVATO REMS program requires this level of oversight for every patient.
A standard course begins with an induction phase of twice-weekly sessions for the first four weeks, followed by a maintenance phase of weekly or biweekly sessions. Your exact schedule will be personalized based on how you respond. Many patients notice meaningful changes within the first few weeks, though individual timelines vary. You remain fully awake throughout each session.
Spravato holds FDA approval for treatment-resistant depression and major depressive disorder with acute suicidal ideation, used alongside an oral antidepressant. Residents from Southfield and the surrounding Berkshire County region turn to our practice when standard antidepressant drugs prove insufficient. Whether you are seeking Spravato for depression, Spravato for treatment-resistant depression, or relief from anxiety symptoms that accompany your depression, our team is prepared to assist.
TRD describes depressive conditions that continue despite trying two or more antidepressant treatments at appropriate dosages. Spravato was specifically developed to address this challenging clinical need, and many major insurance carriers offer coverage for qualifying TRD diagnoses. Spravato for treatment resistant depression represents a targeted alternative when oral medications have not provided adequate relief.
For adults with major depressive disorder who also experience acute suicidal ideation or behavior, Spravato in conjunction with an oral antidepressant is FDA-approved to address depressive symptoms. Spravato for Major Depressive Disorder provides a monitored treatment option for this serious clinical presentation.
While Spravato is not FDA-approved as a standalone treatment for anxiety disorders, many patients with depression also experience significant anxiety symptoms. Spravato for anxiety symptoms that co-occur with depression may provide benefit as part of a comprehensive treatment plan. Your provider will evaluate whether Spravato fits your specific clinical picture.
What makes the Modern Mind Clinic the preferred choice for mental healthcare? Every aspect of our operations is designed to deliver high-quality, stress-free care to residents of Southfield and Berkshire County. When choosing our facility for Spravato treatment near Southfield, you benefit from:
Spravato vs Ketamine: Understanding the Difference
Spravato is the FDA-approved nasal spray form of esketamine, distinct from compounded ketamine infusions. Spravato treatment follows strict REMS protocols with standardized dosing and monitoring requirements, while compounded ketamine lacks FDA approval for depression. Our clinic offers Spravato as a regulated, evidence-based option.
Upfront Insurance Processing
Spravato treatment works best when you can focus on your recovery, not on paperwork. Our team verifies your insurance benefits before your first session, secures prior authorization, and explains exactly what your plan covers.
FDA-Approved, Proven Treatment
Spravato received FDA approval in 2019 for treatment-resistant depression in adults. Clinical studies have evaluated its efficacy and safety in over 1,700 adults with TRD. In the SUSTAIN-3 long-term extension study, 35.6% of patients were in remission at the end of induction, rising to over 50% at one year. (SPRAVATOhcp)
Board-certified interventional psychiatrist specializing in advanced treatments, including Spravato therapy for treatment-resistant depression and other complex mood disorders.
Board-certified psychiatrist providing comprehensive psychiatric care for a wide range of adult psychiatric conditions.
Provides comprehensive psychiatric evaluations, medication management, and treatment coordination for patients undergoing Spravato therapy.
Specializes in psychiatric assessment, medication management, and ongoing patient monitoring throughout the treatment process.
Oversees clinic operations, insurance verification, and patient services to ensure a smooth and stress-free experience for every patient.
Yes, many major health insurance plans cover Spravato therapy for treatment-resistant depression. Commercial insurers and Medicare often cover Spravato when established diagnostic criteria are met, including a documented diagnosis and at least two prior antidepressant trials. The cost of Spravato treatment involves both the medication itself and the administration and monitoring fees. Modern Mind Clinic is in-network with numerous major carriers, and our practice handles all prior authorization documentation on your behalf at no extra charge.
| Insurance | Status | Insurance | Status |
|---|---|---|---|
| Aetna | Accepted | Cigna | Accepted |
| HAP | Accepted | Blue Care Network of Michigan | Accepted |
| BlueCross BlueShield | Accepted | Anthem | Accepted |
| UnitedHealthcare | Accepted | UMR | Accepted |
| Beacon | Accepted | Humana | Accepted |
| Medicaid.gov | Accepted | Medicare | Accepted |
| Molina Healthcare | Accepted | Meridian | Accepted |
| Physicians Health Plan | Accepted | Optum | Accepted |
| MultiPlan | Accepted | TRICARE | Accepted |
Our office is located at 18000 W Nine Mile Rd Suite 750, Southfield,MI 48075, inside the Epicentre (the landmark building visible from the Lodge Freeway).
18000 W Nine Mile Rd Ste 750, Southfield, MI 48075
Parking & access
Free parking is available in the adjacent lot and the multi-level parking structure. Enter through the main lobby (look for the “Epicentre” signage) and take the elevator to Suite 750 on the 7th floor.
The building is fully ADA-accessible. If you have difficulty locating us near the M-10/Southfield Freeway interchange,
please call (248) 213-8655.
Exit at West Nine Mile Road heading west.
The Epicentre complex will be immediately visible on your left as you approach the overpass.
Turn left into the main entrance at 18000 W Nine Mile Rd.
The office is centrally located near the junction of M-10 (Lodge Freeway) and the Southfield Freeway (M-39), making it easily accessible for all of Metro Detroit.
From Great Barrington:
~5–8 min
From Lee:
~5 min
From New Marlborough:
~12–15 min
From Sandisfield:
~10–15 min
~10–15 min
Spravato (esketamine) is an FDA-approved nasal spray medication for treatment-resistant depression and major depressive disorder with acute suicidal ideation in adults. It is administered under medical supervision in a certified Spravato treatment center and requires monitoring for at least two hours after each dose.
Many commercial insurance plans and Medicare cover Spravato for treatment-resistant depression when clinical criteria are met. Coverage typically requires a documented diagnosis and evidence of at least two prior antidepressant trials at adequate dose and duration. Our team handles prior authorization and verification on your behalf.
The cost of Spravato treatment depends on your insurance coverage. Most insured patients pay a copay or coinsurance rather than the full medication cost. Our team verifies your benefits before treatment begins so you know what to expect.
Spravato is an NMDA receptor antagonist that targets glutamate transmission in the brain, which is thought to be abnormally regulated in depression. Unlike traditional antidepressants that affect serotonin or norepinephrine, Spravato works through a different mechanism and may provide relief when other medications have not.
Yes, Spravato contains esketamine, a Schedule III controlled substance. Because of the risks of sedation, dissociation, respiratory depression, and abuse or misuse, it is available only through the SPRAVATO REMS program and must be administered in a certified healthcare setting with monitoring for at least two hours.
The effects of Spravato typically resolve within the two-hour monitoring period, though some patients may feel drowsy for the remainder of the day. You should not drive or operate machinery until the next day after a restful sleep following treatment.
Common side effects include sedation, dissociation, dizziness, nausea, and increased blood pressure. Serious side effects such as respiratory depression are rare but require monitoring. Your provider will assess your blood pressure before each dose and monitor you throughout the session.
Call our team or complete the intake form on this page. Our specialists will verify your insurance benefits, organize your initial consultation, and help you prepare for care. Most patients begin their treatment schedule within one to two weeks.
Most inquiries receive a response within 24 hours. Our practice verifies insurance coverage prior to your arrival, coordinates all prior authorization requirements, and typically schedules session start dates within one to two weeks. Your initial consultation carries zero cost or obligation.
Whether you are ready to begin treatment or exploring Spravato Southfield, MI options, our clinical team is available to answer your questions and guide you forward.
